The clinical course of BPDCN shows progressive systemic expansion, partially attributed to the local production of chemokine ligands of CKR expressed by the tumor cells (CXCR3, CXCR4, CCR6, CCR7) (200). The gene discussed is CXCR4; the disease is neoplasm.